Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...

Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...

Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...

Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...

The most common pathology affecting the pancreas is excess intra-pancreatic fat deposition (IPFD), often called fatty pancreas disease (FPD) — a disorder experienced by roughly one fifth of the ...

The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with type 1 diabetes. Glycemic benefits were similar for adults attending primary care vs.

The 2024 Tesla Model X's interior is extremely simple. The layout is minimalist and dominated by a large touchscreen in the center. Tesla isn't the only player in the game anymore; here are ten ...

It uncovered something worrisome. “I had a mass on my pancreas,” he says. “The doctor there was not ready to tell me I had pancreatic cancer.” The following day, he underwent an MRI ...

A direct connection exists between the pancreas and diabetes. The pancreas is an organ deep in your abdomen behind your stomach. It’s an important part of your digestive system. The pancreas ...

The research team used a Penn-developed immunocompetent model considered the gold standard worldwide for assessing potential therapies for pancreatic ductal adenocarcinoma. This model allows the ...

To help get them prepared for a whole new world of fun, we've put together a list of the best Pokémon model kits to practice with. Targeting first-timers, the majority of these Pokémon model ...

The phase 2 TEDOPaM trial evaluating patients with advanced or metastatic pancreatic ductal adenocarcinoma met its primary end point. The phase 2 TEDOPaM trial evaluating patients with advanced or ...